Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of oxytocin on suggestibility and consciousness
2016-004826-40Phase 2Completed
- Sponsor
- Stockholm University
- Start
- Dec 2016
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, single-arm trial of oxytocin, sponsored by Stockholm University. Primary endpoint: Descriptions of sensory experiences during deprivation. Started Dec 2016; status: completed.
02
Drugs
oxytocin
Beyond the preview
Go deeper on 2016-004826-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-004826-40.